Found: 11
Select item for more details and to access through your institution.
Modelization of the regulation of protein synthesis following fertilization in sea urchin shows requirement of two processes: a destabilization of eIF4E:4E-BP complex and a great stimulation of the 4E-BP-degradation mechanism, both rapamycin-sensitive.
- Published in:
- Frontiers in Genetics, 2014, v. 5, p. 1, doi. 10.3389/fgene.2014.00117
- By:
- Publication type:
- Article
Glucocorticoid withdrawal and glucocorticoid-induced adrenal insufficiency: Study protocol of the randomized controlled «TOASST" (Taper Or Abrupt Steroid STop) multicenter trial.
- Published in:
- PLoS ONE, 2023, v. 18, n. 4, p. 1, doi. 10.1371/journal.pone.0281585
- By:
- Publication type:
- Article
Adenosine integrates light and sleep signalling for the regulation of circadian timing in mice.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-22179-z
- By:
- Publication type:
- Article
Tracking a refined eIF4E-binding motif reveals Angel1 as a new partner of eIF4E.
- Published in:
- Nucleic Acids Research, 2013, v. 41, n. 16, p. 7783, doi. 10.1093/nar/gkt569
- By:
- Publication type:
- Article
The translational repressor 4E-BP called to order by eIF4E: new structural insights by SAXS.
- Published in:
- Nucleic Acids Research, 2011, v. 39, n. 8, p. 3496, doi. 10.1093/nar/gkq1306
- By:
- Publication type:
- Article
Ether lipids, sphingolipids and toxic 1‐deoxyceramides as hallmarks for lean and obese type 2 diabetic patients.
- Published in:
- Acta Physiologica, 2021, v. 232, n. 1, p. 1, doi. 10.1111/apha.13610
- By:
- Publication type:
- Article
Liquid Biopsy for Patient Characterization in Cardiovascular Disease: Verification against Markers of Cytochrome P450 and P‐Glycoprotein Activities.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 6, p. 1268, doi. 10.1002/cpt.2576
- By:
- Publication type:
- Article
Apixaban and rivaroxaban's physiologically‐based pharmacokinetic model validation in hospitalized patients: A first step for larger use of a priori modeling approach at bed side.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2023, v. 12, n. 12, p. 1872, doi. 10.1002/psp4.13036
- By:
- Publication type:
- Article
Population pharmacokinetics of apixaban in a real‐life hospitalized population from the OptimAT study.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2023, v. 12, n. 10, p. 1541, doi. 10.1002/psp4.13032
- By:
- Publication type:
- Article
Impact of the Genotype and Phenotype of CYP3A and P-gp on the Apixaban and Rivaroxaban Exposure in a Real-World Setting.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 4, p. 526, doi. 10.3390/jpm12040526
- By:
- Publication type:
- Article
Dexamethasone exposure in normal‐weight and obese hospitalized COVID‐19 patients: An observational exploratory trial.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 7, p. 1796, doi. 10.1111/cts.13297
- By:
- Publication type:
- Article